COVID-19 and this year's research period
March 31, 2020
A note from the editor as we deal with the epidemic
| Lawyer | Section | Practice Area | Location |
|---|---|---|---|
| Korpus, Sheron | Non-IP Litigation & Enforcement | Antitrust | New York City |
| Toney, Jeffrey | Intellectual Property | Hatch-Waxman Patent Litigation, General Patent Litigation | Atlanta |
| , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} |
Non-IP Litigation & Enforcement
Kasowitz Benson Torres is a New York-based litigation boutique with a growing presence in the life sciences sector. The firm is particularly notable for its work in antitrust litigation. Sheron Korpus has extensive experience litigating on behalf of life sciences clients in complex antitrust cases. Among his recent matters, Korpus is active for generic giant Teva and its US subsidiary Actavis in numerous class action cases consolidated into a multidistrict litigation in the Eastern District of Pennsylvania. The matter involves claims of alleged price fixing, and is one of the largest current pharmaceutical litigations in the US.
Articles
2020 research cycle for US and Canada has officially launched!
March 25, 2020
Now accepting submissions for firm rankings and awards